447 related articles for article (PubMed ID: 16307498)
1. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
Patel SN; Kain KC
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
3. [What is the value of the combination atovaquone-proguanil for the clinician?].
Delmont J
Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
[TBL] [Abstract][Full Text] [Related]
4. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Kain KC; Shanks GD; Keystone JS
Clin Infect Dis; 2001 Jul; 33(2):226-34. PubMed ID: 11418883
[TBL] [Abstract][Full Text] [Related]
5. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
[TBL] [Abstract][Full Text] [Related]
6. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Kuhn S; Gill MJ; Kain KC
Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
8. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
Lundgren JD; Dragsted UB
Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
[TBL] [Abstract][Full Text] [Related]
9. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone-proguanil for prophylaxis and treatment of malaria.
Marra F; Salzman JR; Ensom MH
Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
[TBL] [Abstract][Full Text] [Related]
11. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
[TBL] [Abstract][Full Text] [Related]
13. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
[TBL] [Abstract][Full Text] [Related]
14. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Schwartz E; Bujanover S; Kain KC
Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
[TBL] [Abstract][Full Text] [Related]
15. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
[TBL] [Abstract][Full Text] [Related]
16. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
17. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
[TBL] [Abstract][Full Text] [Related]
18. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F
Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569
[TBL] [Abstract][Full Text] [Related]
19. Atovaquone-proguanil for falciparum malaria in the Philippines.
Watt G
J Infect Dis; 2000 Jan; 181(1):405. PubMed ID: 10608798
[No Abstract] [Full Text] [Related]
20. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
